Brief: Sanofi India Says Gujarat Facility Sale Unlikely To Close By March 31 Due To Delay In Regulatory Approvals
27/03/2020 07:18
March 27 (Reuters) - Sanofi India Ltd SANO.NS :
* DUE TO DELAY IN GETTING REGULATORY APPROVALS, CLOSING OF
DEAL TO
SELL GUJARAT MANUFACTURING FACILITY NOT LIKELY BY MARCH 31
* NOW EXPECTS DEAL WILL CLOSE DURING QUARTER ENDING JUNE 30,
2020
Source text: https://www.bseindia.com/xml-data/corpfiling/AttachLive/f386cb04-13bb-4d04-a80d-37b0bdb84379.pdf
Further company coverage: SANO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sanofi India
See all newsSanofi India gains as quarterly profit doubles on strong diabetes business performance
Brief: Sanofi India Sept-Quarter Profit 1.17 Billion Rupees
Brief: Sanofi India Gets Tax Notice Worth 164 Million Rupees
Brief: Sanofi India Says Supreme Court Of India Has Dismissed Co's Petition Seeking Quashing Of Criminal Proceedings
Brief: Sanofi India Says Tax Demand Of 7.3 Million Rupees Vacated For AY 2019-20